Our results correlate with the findings of Pinos et al. [6] who reported that ovarian and colorectal cancer cell lines are most sensitive to the modulation of Syk alternative splicing rather than the global knockdown of Syk expression which does not mimic the effects of alternative splicing on cell survival and apoptosis. Here, SYK is linked to colorectal cancer.